MedTrace Logo

Genetic Contribution to the Pathophysiology of the Charcot Foot in Qatari Patients With Diabetes

NCT02316483 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2020-01-14

No results posted yet for this study

Summary

To assess the hypothesis that Charcot foot is associated with more vascular complications compared to matched diabetic patients without Charcot foot and to classify patients with Charcot foot according to the human genetic classification of the Qatari population.

Conditions

Sponsors & Collaborators

  • Hamad Medical Corporation

    collaborator INDUSTRY

  • Weill Cornell Medical College in Qatar

    collaborator OTHER

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Charbel Abi Khalil, MD · Weill Cornell Medical College in Qatar

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2018-12-31
Completion
2019-12-31

Countries

  • Qatar

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02316483 on ClinicalTrials.gov